grmqgq
Lv41
640 积分
2022-06-08 加入
-
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
3天前
已完结
-
DDR1-targeted therapies: current limitations and future potential
1个月前
已完结
-
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
1个月前
已完结
-
c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy
1个月前
已完结
-
A β-1,3/1,6-glucan enhances anti-tumor effects of PD1 antibody by reprogramming tumor microenvironment
1个月前
已完结
-
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
1个月前
已完结
-
Azithromycin 1.5 % ophthalmic solution: a guide to its use in purulent bacterial conjunctivitis and trachomatous conjunctivitis
2个月前
已完结
-
The Premature Ejaculation Profile: validation of self‐reported outcome measures for research and practice
2个月前
已完结
-
Development and Validation of a New Questionnaire to Assess Sexual Satisfaction, Control, and Distress Associated with Premature Ejaculation
2个月前
已完结
-
Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine
2个月前
已完结